| 1 |
30348903 | Mechanistic In Vitro Studies Indicate that the Clinical Drug-Drug Interaction between Telithromycin and Simvastatin Acid Is Driven by Time-Dependent Inhibition of CYP3A4 with Minimal Effect on OATP1B1. | 2019 Jan |
4 |
| 2 |
24114622 | Pharmacology of the new P2Y12 receptor inhibitors: insights on pharmacokinetic and pharmacodynamic properties. | 2013 Oct |
1 |
| 3 |
22398966 | Predicting drug interaction potential with a physiologically based pharmacokinetic model: a case study of telithromycin, a time-dependent CYP3A inhibitor. | 2012 Apr |
2 |
| 4 |
19755414 | Effect of telithromycin on the pharmacokinetics and pharmacodynamics of oral oxycodone. | 2010 Jan |
1 |
| 5 |
18558790 | Benefit-risk assessment of telithromycin in the treatment of community-acquired pneumonia. | 2008 |
2 |
| 6 |
18976719 | Time-dependent effects of Klebsiella pneumoniae endotoxin on the telithromycin pharmacokinetics in rats; restoration of the parameters in 96-hour KPLPS rats to the control levels. | 2008 Dec |
1 |
| 7 |
16513447 | Telithromycin, but not montelukast, increases the plasma concentrations and effects of the cytochrome P450 3A4 and 2C8 substrate repaglinide. | 2006 Mar |
3 |
| 8 |
16556082 | Drug interactions during therapy with three major groups of antimicrobial agents. | 2006 Apr |
1 |
| 9 |
15598962 | Verapamil toxicity resulting from a probable interaction with telithromycin. | 2005 Feb |
1 |
| 10 |
15792396 | Effect of ketoconazole on the pharmacokinetics and safety of telithromycin and clarithromycin in older subjects with renal impairment. | 2005 Mar |
1 |
| 11 |
16122280 | Clinical pharmacokinetics of telithromycin, the first ketolide antibacterial. | 2005 |
3 |
| 12 |
16199242 | Telithromycin: the first ketolide antimicrobial. | 2005 Aug |
1 |
| 13 |
16238904 | Pharmacokinetics of telithromycin: application to dosing in the treatment of community-acquired respiratory tract infections. | 2005 Oct |
1 |